ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IKNA Ikena Oncology Inc

1.31
0.00 (0.00%)
May 06 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ikena Oncology Inc IKNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.31 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.31
more quote information »

Recent News

Date Time Source Heading
4/10/202407:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
3/12/202407:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
3/05/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/27/202407:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
2/21/202415:29EDGAR2Form 8-K - Current report
2/21/202415:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
2/02/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202415:26EDGAR2Form 8-K - Current report
1/18/202415:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
11/09/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:09EDGAR2Form 8-K - Current report
11/09/202306:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
11/07/202307:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
10/11/202316:10EDGAR2Form 8-K - Current report
9/25/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
9/15/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
9/12/202315:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/10/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
9/05/202307:00GLOBEIkena Oncology to Participate in September 2023 Investor..
8/18/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
8/10/202307:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
8/10/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:02EDGAR2Form 8-K - Current report
8/07/202306:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
6/30/202316:15EDGAR2Form 8-K - Current report
5/24/202307:00GLOBEIkena Oncology to Participate in Upcoming Investor..
5/15/202306:50GLOBEIkena Oncology Reports First Quarter 2023 Financial Results..
5/15/202306:45GLOBEIkena Oncology Announces $40 Million Underwritten Offering

Your Recent History

Delayed Upgrade Clock